USPTO serial 85126009
Reviewed by CopyMark Law Group
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Minato-ku, Tokyo, JP
Minato-ku, Tokyo, JP
Minato-ku, Tokyo, JP
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Doreen L. Costa
DOREEN L. COSTA BAKER BOTTS LLP30 ROCKEFELLER PLZ FL 44NEW YORK, NY 10112-0015UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical powders and emulsifiers for use in the manufacture of health foods and supplements; chemical powders and emulsifiers for use in the manufacture of cosmetics; chemicals for use in the manufacture of pharmaceutical preparations; chemical preparations for general industrial manufacturing | SECTION 8 - CANCELLED | — |
| 003 | Cosmetics; non-medicated toiletries; soaps; detergents for household use; dentifrices, fragrances and perfumery, incenses; false nails; false eyelashes; Anti-static preparations for household purposes; De-greasing preparations for household purposes; rust removing preparations; stain removing preparations; fabric softeners for laundry use; laundry bleaches | SECTION 8 - CANCELLED | — |
| 005 | Pharmaceutical preparations, namely, central nervous system agents, peripheral nervous system agents, sensory organ agents, miscellaneous nervous system and sensory organ agents, cardiovascular agents, respiratory organ agents, digestive organ agents, hormones, urogenital and anal organ agents, epidermides, dental preparations, miscellaneous organ agents, vitamins, nutrients, tonics, blood and body fluid agents, dialysis agents, miscellaneous metabolism agents, cellular function activating agents, antineoplastics, radioactive drugs, allergic agents, miscellaneous cellular function agents, crude drugs and traditional Chinese medicines, antibiotics, chemotherapeutics, biological preparations, parasitics (systemic), pathogenic organism agents, dispensing medicines, intracorporeal diagnostic agents, public health agents, extracorporeal diagnostic agents, non-main therapeutic purpose agents, alkaloidal narcotics, non-alkaloidal narcotics and miscellaneous narcotics; sanitary preparations for medical use; sanitary masks for medical purposes; drug delivery agents in the form of pharmaceutical wafers and gelatin-starch films for providing controlled release of the active ingredients for a wide variety of pharmaceuticals; gauze; empty capsules for pharmaceuticals; eye patches for medical purposes; bandages for skin wounds for use on the ear; sanitary pads; menstruation tampons; sanitary napkins; sanitary panties; cotton for medical purposes; bandages for skin wounds, medical plasters, medical dressings; medical dressing in liquid form, medical dressing containing collodion for pharmaceutical purposes; breast-nursing pads; dental composite materials; incontinence diapers; dietetic lactic sugar for medical use; powdered milk for infants; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing astaxanthin as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing ceramide as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing vitamin E as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing lycopene as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing vitamin C as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing selenium yeast as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing zinc yeast as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing salacia extract powder as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing onion integument extract as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing chitosan as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing apple polyphenol as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing tea catechin as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing chromium yeast as a principal ingredient | SECTION 8 - CANCELLED | — |
| 035 | Retail store services or wholesale store services for pharmaceuticals, sanitary preparations and medical supplies; retail store services or wholesale store services featuring cosmetics and toiletries; retail store services or wholesale store services featuring processed foods; online retail store services and wholesale store services featuring pharmaceuticals, sanitary preparations and medical supplies; online retail store services and wholesale store services featuring cosmetics and toiletries; online retail store services and wholesale store services featuring processed foods; advertising in websites on the Internet; providing businesses information through websites on the Internet; providing consumer products information through websites on the Internet | SECTION 8 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 18, 2019 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jun 12, 2017 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jun 12, 2012 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 27, 2012 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 27, 2012 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 7, 2012 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 22, 2012 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Feb 16, 2012 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 26, 2012 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 26, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 17, 2012 | ALIE | ASSIGNED TO LIE | — |
| Jan 5, 2012 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Nov 27, 2011 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Nov 27, 2011 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 27, 2011 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 26, 2011 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 26, 2011 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 26, 2011 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Jul 14, 2011 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jul 14, 2011 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jul 14, 2011 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jun 16, 2011 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 16, 2011 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 16, 2011 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 18, 2010 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 18, 2010 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 18, 2010 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 17, 2010 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 15, 2010 | MPMK | NOTICE OF PSEUDO MARK MAILED | — |
| Sep 14, 2010 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 13, 2010 | NWAP | NEW APPLICATION ENTERED | — |